International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk?
2012/04/24 by Friederike Erdmann, Joannie Lortet‐Tieulent, Joachim Schüz +4 · 28 citations
Medicine · #Cutaneous Melanoma Detection and Management #Skin Protection and Aging #Allergic Rhinitis and Sensitization
paper · doi:10.1002/ijc.27616
Abstract
The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair-skinned populations. This increase is reported to have leveled off recently in several Northern and Western European countries, Australia, New Zealand and in North America. We studied the global patterns and time trends in incidence of melanoma by country and sex, with a focus on and age- and cohort-specific variations. We analyzed the incidence data from 39 population-based cancer registries, examining all-ages and age-truncated standardized incidence rates of melanoma, estimating the annual percentage change and incidence rate ratios from age-period-cohort models. Incidence rates of melanoma continue to rise in most European countries (primarily Southern and Eastern Europe), whereas in Australia, New Zealand, the U.S., Canada, Israel and Norway, rates have become rather stable in recent years. Indications of a stabilization or decreasing trend were observed mainly in the youngest age group (25-44 years). Rates have been rising steadily in generations born up to the end of the 1940s, followed by a stabilization or decline in rates for more recently born cohorts in Australia, New Zealand, the U.S., Canada and Norway. In addition to the birth cohort effect, there was a suggestion of a period-related influence on melanoma trends in certain populations. Although our findings provide support that primary and secondary prevention can halt and reverse the observed increasing burden of melanoma, they also indicate that those prevention measures require further endorsement in many countries.
Cited by
- Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
- Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036
- Phytochemicals for the Management of Melanoma. [europepmc]
- The Potential of Plant Phenolics in Prevention and Therapy of Skin Disorders. [europepmc]
- The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4. [europepmc]
- Oncogenic BRAF-Mediated Melanoma Cell Invasion. [europepmc]
- Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers. [europepmc]
- Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches. [europepmc]
- The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a. [europepmc]
- Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe). [europepmc]
- Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma. [europepmc]
- Clinical Perspective of 3D Total Body Photography for Early Detection and Screening of Melanoma. [europepmc]
- Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults. [europepmc]
- Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. [europepmc]
- High-frequency ultrasound for diagnosing skin cancer in adults. [europepmc]
- Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma. [europepmc]
- Teledermatology for diagnosing skin cancer in adults. [europepmc]
- Optical coherence tomography for diagnosing skin cancer in adults. [europepmc]
- Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults. [europepmc]
- Cancer statistics for adults aged 85 years and older, 2019. [europepmc]
- Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis. [europepmc]
- The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy. [europepmc]
- The discovery and development of binimetinib for the treatment of melanoma. [europepmc]
- The influence of climate change on skin cancer incidence - A review of the evidence. [europepmc]
- Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981-2018. [europepmc]
- Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects. [europepmc]
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. [europepmc]
Related